News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Archemix Corporation and SomaLogic Expand Strategic Alliance
August 8, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CAMBRIDGE, Mass. & BOULDER, Colo.--(BUSINESS WIRE)--Archemix Corp. and SomaLogic, Inc. announced today an expansion of their alliance focused on the use and development of aptamers for therapeutic, diagnostic, and other applications.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Somalogic, Inc.
MORE ON THIS TOPIC
Manufacturing
Sun Pharma recalls cancer drug after finding glass particles in some vials
May 15, 2026
·
2 min read
·
Nick Paul Taylor
Drug Development
Biogen’s Alzheimer’s results bolster tau theory—and Denali’s next gen candidate
May 15, 2026
·
3 min read
·
Annalee Armstrong
Series B
CREATE jumps into CAR T competition with $122M series B
May 15, 2026
·
2 min read
·
Tristan Manalac
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
May 14, 2026
·
2 min read
·
Tristan Manalac